Integrating Omics Approaches

On the Road to 2021, Andis Slaitas, General Manager of MGI Latvia, discusses the next level of omics approaches.

Nice Insight

Nice Insight, established in 2010, is the research division of That’s Nice, A Science Agency, providing data and analysis from proprietary annual surveys, custom primary qualitative and quantitative research as well as extensive secondary research. Current annual surveys include The Nice Insight Contract Development & Manufacturing (CDMO/CMO), Survey The Nice Insight Contract Research - Preclinical and Clinical (CRO) Survey, The Nice Insight Pharmaceutical Equipment Survey, and The Nice Insight Pharmaceutical Excipients Survey.

MGI Latvia

MGI Latvia is a subsidiary of MGI Tech Co., Ltd. (MGI), a global leader in life science innovation, established in 2016 and now operating in more than 50 countries and regions, serving more than 1000 customers worldwide. MGI is committed to enabling effective and affordable healthcare solutions for all. Based on its proprietary technology, MGI’s multi-omics platforms include reagents, medical imaging, laboratory automation and genetic sequencing.  Providing real-time, comprehensive, life-long solutions, MGI’s mission is to develop and promote advanced life science tools for future healthcare.

MGI Latvia acts as a hub of research and development, production, logistics and specialized training for MGI’s business development in Europe and other international regions. The 7,500m2 facility has a Global Product Application Demo Centre and a state-of-art Sequencing Centre. The company’s customers and partners include research centres, universities, public and private healthcare institutions and diagnostics laboratories.

Q: